
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideo
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2023 Pride Publishing Inc.
All Rights reserved
All Rights reserved
Scroll To Top
By continuing to use our site, you agree to our Private Policy and Terms of Use.
There's good news for HIVers coinfected with hepatitis C. Coinfection does not hamper the immune system's ability to rebound on a successful antiretroviral regimen. Previous research has shown that HIV infection does accelerate liver disease progression caused by hep C, and there were fears that hepatitis C may have a similar reverse effect on HIV disease or on the ability of anti-HIV medications to suppress the virus and boost CD4-cell counts. But a study of more than 4,000 coinfected adults reported in the Journal of Acquired Immune Deficiency Syndromes seems to put those worries to rest. Data showed that there was not a difference in CD4-cell rebounds between coinfected adults and those with only HIV infection. There's one caveat, though. The study included only HIV-HCVers with fully suppressed HIV viral loads. 'We cannot evaluate the influence of HCV coinfection on the CD4-cell count in patients who are not fully suppressed,' the researchers said.
From our Sponsors
Most Popular
Plus: Featured Video